Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osamu Matsuo

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Pathophysiology : the Official Journal of the International Society for Pathophysiology|June 9, 2009
Roles of fibrinolytic system components in the nervous systemNobuo Nagai, Osamu Matsuo
Current Pharmaceutical Design|March 7, 2006
Development of new fibrinolytic agentsShigeru Ueshima, Osamu Matsuo
Cardiology in the Young|June 3, 2022
Torsion of wandering spleen after Fontan operation in a patient with situs inversus: a rare complicationFumiya Miyamura, Osamu Matsuo, Kimitoshi Nakamura
Immunity, Inflammation and Disease|September 14, 2016
The blocking of uPAR suppresses lipopolysaccharide-induced inflammatory osteoclastogenesis and the resultant bone loss through attenuation of integrin β3/Akt pathwayYosuke Kanno, Akira Ishisaki, Mei Miyashita, et al.
Thrombosis Research|April 15, 2004
Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cellsShigeru Ueshima, Hideharu Fukao, Kiyotaka Okada, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|October 22, 2003
Suppression of the release of type-1 plasminogen activator inhibitor from human vascular endothelial cells by Hawaii deep sea waterShigeru Ueshima, Hideharu Fukao, Kiyotaka Okada, et al.
Immunity, Inflammation and Disease|April 3, 2020
α2AP is associated with the development of lupus nephritis through the regulation of plasmin inhibition and inflammatory responsesYosuke Kanno, Mei Miyashita, Mariko Seishima, et al.
Molecular Biology Reports|October 28, 2021
α2-antiplasmin positively regulates endothelial-to-mesenchymal transition and fibrosis progression in diabetic nephropathyYosuke Kanno, Momoko Hirota, Osamu Matsuo, et al.
Journal of Vascular Research|March 14, 2026
Plasmin-PAI-1 Imbalance Contributes to Hyperglycemia-Induced Vascular CalcificationYosuke Kanno, Moeko Okuno, Osamu Matsuo, et al.
Seminars in Thrombosis and Hemostasis|January 22, 2003
Influence of low- and high-molecular-weight plasminogen activators on the onset of labor and on the hemostatic systemTakanori Moriyama, Shigenori Suzuki, Kazuhiko Matsuno, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Pathophysiology : the Official Journal of the International Society for Pathophysiology|June 9, 2009
Roles of fibrinolytic system components in the nervous systemNobuo Nagai, Osamu Matsuo
Current Pharmaceutical Design|March 7, 2006
Development of new fibrinolytic agentsShigeru Ueshima, Osamu Matsuo
Cardiology in the Young|June 3, 2022
Torsion of wandering spleen after Fontan operation in a patient with situs inversus: a rare complicationFumiya Miyamura, Osamu Matsuo, Kimitoshi Nakamura
Immunity, Inflammation and Disease|September 14, 2016
The blocking of uPAR suppresses lipopolysaccharide-induced inflammatory osteoclastogenesis and the resultant bone loss through attenuation of integrin β3/Akt pathwayYosuke Kanno, Akira Ishisaki, Mei Miyashita, et al.
Thrombosis Research|April 15, 2004
Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cellsShigeru Ueshima, Hideharu Fukao, Kiyotaka Okada, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|October 22, 2003
Suppression of the release of type-1 plasminogen activator inhibitor from human vascular endothelial cells by Hawaii deep sea waterShigeru Ueshima, Hideharu Fukao, Kiyotaka Okada, et al.
Immunity, Inflammation and Disease|April 3, 2020
α2AP is associated with the development of lupus nephritis through the regulation of plasmin inhibition and inflammatory responsesYosuke Kanno, Mei Miyashita, Mariko Seishima, et al.
Molecular Biology Reports|October 28, 2021
α2-antiplasmin positively regulates endothelial-to-mesenchymal transition and fibrosis progression in diabetic nephropathyYosuke Kanno, Momoko Hirota, Osamu Matsuo, et al.
Journal of Vascular Research|March 14, 2026
Plasmin-PAI-1 Imbalance Contributes to Hyperglycemia-Induced Vascular CalcificationYosuke Kanno, Moeko Okuno, Osamu Matsuo, et al.
Seminars in Thrombosis and Hemostasis|January 22, 2003
Influence of low- and high-molecular-weight plasminogen activators on the onset of labor and on the hemostatic systemTakanori Moriyama, Shigenori Suzuki, Kazuhiko Matsuno, et al.
Pageof 11